Premium
A pharmacogenetic study of escitalopram in autism spectrum disorders
Author(s) -
Owley Thomas,
Brune Camille W.,
Salt Jeff,
Walton Laura,
Guter Steve,
Ayuyao Nelson,
Gibbons Robert D.,
Leventhal Bennett L.,
Cook Edwin H.
Publication year - 2010
Publication title -
autism research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 66
eISSN - 1939-3806
pISSN - 1939-3792
DOI - 10.1002/aur.109
Subject(s) - escitalopram , irritability , genotype , autism spectrum disorder , serotonin transporter , autism , psychology , citalopram , psychiatry , clinical psychology , medicine , genetics , cognition , anxiety , biology , gene , antidepressant
To determine the effect of serotonin transporter polymorphism promoter region (5-HTTPLR) genotypic variation (low, intermediate, and high expression groups) on response to escitalopram treatment of children and adolescents with autism spectrum disorders (ASDs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom